capture probes Search Results


mgieasy exome capture v5 probe set  (Complete Genomics Inc)
97
Complete Genomics Inc mgieasy exome capture v5 probe set
Key challenges encountered during autonomous WES implementation in Algeria, with contextual evidence and implemented or planned solutions. Challenges operate at two interconnected levels: interpretive (dark grey, relating to population underrepresentation, VUS burden, and consanguinity) and ethical/structural (medium grey, relating to incidental findings, infrastructure, and territorial access). Each challenge is paired with its evidentiary context and the corresponding response developed within this programme. ACMG, American College of Medical Genetics and Genomics; AI, artificial intelligence (here: in-house computational tools for variant prioritisation and interpretation); AMinGen, Application for Medical Inquiry and Nexus in Genornics (national clinical genetics referral platform); AMP, Association for Molecular Pathology; ATM, ataxia telangiectasia mutated gene; CERIST, ResearchCentre for Scientific and Technical Information; DzNA, Database of Algerian variants and allele frequencies; HPO, Human Phenotype Ontology; MH, malignant hyperthermia; ROH, runs of homozygosity; RYRl, ryanodine receptor 1 gene; VUS, variant of uncertain significance; WES, <t>whole-exome</t> sequencing.
Mgieasy Exome Capture V5 Probe Set, supplied by Complete Genomics Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capture+probes/med_rxiv__64898__2026__03__23__26348909-22-19-25?v=Complete+Genomics+Inc
Average 97 stars, based on 1 article reviews
mgieasy exome capture v5 probe set - by Bioz Stars, 2026-08
97/100 stars
  Buy from Supplier
probe-capture-targeted method  (MyGenostics Inc)
90
MyGenostics Inc probe-capture-targeted method
Key challenges encountered during autonomous WES implementation in Algeria, with contextual evidence and implemented or planned solutions. Challenges operate at two interconnected levels: interpretive (dark grey, relating to population underrepresentation, VUS burden, and consanguinity) and ethical/structural (medium grey, relating to incidental findings, infrastructure, and territorial access). Each challenge is paired with its evidentiary context and the corresponding response developed within this programme. ACMG, American College of Medical Genetics and Genomics; AI, artificial intelligence (here: in-house computational tools for variant prioritisation and interpretation); AMinGen, Application for Medical Inquiry and Nexus in Genornics (national clinical genetics referral platform); AMP, Association for Molecular Pathology; ATM, ataxia telangiectasia mutated gene; CERIST, ResearchCentre for Scientific and Technical Information; DzNA, Database of Algerian variants and allele frequencies; HPO, Human Phenotype Ontology; MH, malignant hyperthermia; ROH, runs of homozygosity; RYRl, ryanodine receptor 1 gene; VUS, variant of uncertain significance; WES, <t>whole-exome</t> sequencing.
Probe Capture Targeted Method, supplied by MyGenostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capture+probes/pmc11610102-57-24-26?v=MyGenostics+Inc
Average 90 stars, based on 1 article reviews
probe-capture-targeted method - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
c-probes, capture probes and ram primers  (Gene Link Inc)
90
Gene Link Inc c-probes, capture probes and ram primers
Key challenges encountered during autonomous WES implementation in Algeria, with contextual evidence and implemented or planned solutions. Challenges operate at two interconnected levels: interpretive (dark grey, relating to population underrepresentation, VUS burden, and consanguinity) and ethical/structural (medium grey, relating to incidental findings, infrastructure, and territorial access). Each challenge is paired with its evidentiary context and the corresponding response developed within this programme. ACMG, American College of Medical Genetics and Genomics; AI, artificial intelligence (here: in-house computational tools for variant prioritisation and interpretation); AMinGen, Application for Medical Inquiry and Nexus in Genornics (national clinical genetics referral platform); AMP, Association for Molecular Pathology; ATM, ataxia telangiectasia mutated gene; CERIST, ResearchCentre for Scientific and Technical Information; DzNA, Database of Algerian variants and allele frequencies; HPO, Human Phenotype Ontology; MH, malignant hyperthermia; ROH, runs of homozygosity; RYRl, ryanodine receptor 1 gene; VUS, variant of uncertain significance; WES, <t>whole-exome</t> sequencing.
C Probes, Capture Probes And Ram Primers, supplied by Gene Link Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capture+probes/pmc03664557-114-5-10?v=Gene+Link+Inc
Average 90 stars, based on 1 article reviews
c-probes, capture probes and ram primers - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
biotinylated capture probe  (MyGenostics Inc)
90
MyGenostics Inc biotinylated capture probe
Key challenges encountered during autonomous WES implementation in Algeria, with contextual evidence and implemented or planned solutions. Challenges operate at two interconnected levels: interpretive (dark grey, relating to population underrepresentation, VUS burden, and consanguinity) and ethical/structural (medium grey, relating to incidental findings, infrastructure, and territorial access). Each challenge is paired with its evidentiary context and the corresponding response developed within this programme. ACMG, American College of Medical Genetics and Genomics; AI, artificial intelligence (here: in-house computational tools for variant prioritisation and interpretation); AMinGen, Application for Medical Inquiry and Nexus in Genornics (national clinical genetics referral platform); AMP, Association for Molecular Pathology; ATM, ataxia telangiectasia mutated gene; CERIST, ResearchCentre for Scientific and Technical Information; DzNA, Database of Algerian variants and allele frequencies; HPO, Human Phenotype Ontology; MH, malignant hyperthermia; ROH, runs of homozygosity; RYRl, ryanodine receptor 1 gene; VUS, variant of uncertain significance; WES, <t>whole-exome</t> sequencing.
Biotinylated Capture Probe, supplied by MyGenostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capture+probes/pmc04490691-50-7-10?v=MyGenostics+Inc
Average 90 stars, based on 1 article reviews
biotinylated capture probe - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
bgi exome capture v4 probe  (BGI Shenzhen)
90
BGI Shenzhen bgi exome capture v4 probe
Key challenges encountered during autonomous WES implementation in Algeria, with contextual evidence and implemented or planned solutions. Challenges operate at two interconnected levels: interpretive (dark grey, relating to population underrepresentation, VUS burden, and consanguinity) and ethical/structural (medium grey, relating to incidental findings, infrastructure, and territorial access). Each challenge is paired with its evidentiary context and the corresponding response developed within this programme. ACMG, American College of Medical Genetics and Genomics; AI, artificial intelligence (here: in-house computational tools for variant prioritisation and interpretation); AMinGen, Application for Medical Inquiry and Nexus in Genornics (national clinical genetics referral platform); AMP, Association for Molecular Pathology; ATM, ataxia telangiectasia mutated gene; CERIST, ResearchCentre for Scientific and Technical Information; DzNA, Database of Algerian variants and allele frequencies; HPO, Human Phenotype Ontology; MH, malignant hyperthermia; ROH, runs of homozygosity; RYRl, ryanodine receptor 1 gene; VUS, variant of uncertain significance; WES, <t>whole-exome</t> sequencing.
Bgi Exome Capture V4 Probe, supplied by BGI Shenzhen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capture+probes/pm35959968-61-12-17?v=BGI+Shenzhen
Average 90 stars, based on 1 article reviews
bgi exome capture v4 probe - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
gencaptm human whole exon probe v4.0  (MyGenostics Inc)
90
MyGenostics Inc gencaptm human whole exon probe v4.0
Key challenges encountered during autonomous WES implementation in Algeria, with contextual evidence and implemented or planned solutions. Challenges operate at two interconnected levels: interpretive (dark grey, relating to population underrepresentation, VUS burden, and consanguinity) and ethical/structural (medium grey, relating to incidental findings, infrastructure, and territorial access). Each challenge is paired with its evidentiary context and the corresponding response developed within this programme. ACMG, American College of Medical Genetics and Genomics; AI, artificial intelligence (here: in-house computational tools for variant prioritisation and interpretation); AMinGen, Application for Medical Inquiry and Nexus in Genornics (national clinical genetics referral platform); AMP, Association for Molecular Pathology; ATM, ataxia telangiectasia mutated gene; CERIST, ResearchCentre for Scientific and Technical Information; DzNA, Database of Algerian variants and allele frequencies; HPO, Human Phenotype Ontology; MH, malignant hyperthermia; ROH, runs of homozygosity; RYRl, ryanodine receptor 1 gene; VUS, variant of uncertain significance; WES, <t>whole-exome</t> sequencing.
Gencaptm Human Whole Exon Probe V4.0, supplied by MyGenostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capture+probes/pmc11283671-44-5-11?v=MyGenostics+Inc
Average 90 stars, based on 1 article reviews
gencaptm human whole exon probe v4.0 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
dna capture probes incorporating thiol (sh-dna) 5’-end  (IBIAN Technologies Co)
90
IBIAN Technologies Co dna capture probes incorporating thiol (sh-dna) 5’-end
Key challenges encountered during autonomous WES implementation in Algeria, with contextual evidence and implemented or planned solutions. Challenges operate at two interconnected levels: interpretive (dark grey, relating to population underrepresentation, VUS burden, and consanguinity) and ethical/structural (medium grey, relating to incidental findings, infrastructure, and territorial access). Each challenge is paired with its evidentiary context and the corresponding response developed within this programme. ACMG, American College of Medical Genetics and Genomics; AI, artificial intelligence (here: in-house computational tools for variant prioritisation and interpretation); AMinGen, Application for Medical Inquiry and Nexus in Genornics (national clinical genetics referral platform); AMP, Association for Molecular Pathology; ATM, ataxia telangiectasia mutated gene; CERIST, ResearchCentre for Scientific and Technical Information; DzNA, Database of Algerian variants and allele frequencies; HPO, Human Phenotype Ontology; MH, malignant hyperthermia; ROH, runs of homozygosity; RYRl, ryanodine receptor 1 gene; VUS, variant of uncertain significance; WES, <t>whole-exome</t> sequencing.
Dna Capture Probes Incorporating Thiol (Sh Dna) 5’ End, supplied by IBIAN Technologies Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capture+probes/10__1016_slash_j__aca__2019__05__038-68-4-12?v=IBIAN+Technologies+Co
Average 90 stars, based on 1 article reviews
dna capture probes incorporating thiol (sh-dna) 5’-end - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
dna double-stranded capture probe m010  (MyGenostics Inc)
90
MyGenostics Inc dna double-stranded capture probe m010
Key challenges encountered during autonomous WES implementation in Algeria, with contextual evidence and implemented or planned solutions. Challenges operate at two interconnected levels: interpretive (dark grey, relating to population underrepresentation, VUS burden, and consanguinity) and ethical/structural (medium grey, relating to incidental findings, infrastructure, and territorial access). Each challenge is paired with its evidentiary context and the corresponding response developed within this programme. ACMG, American College of Medical Genetics and Genomics; AI, artificial intelligence (here: in-house computational tools for variant prioritisation and interpretation); AMinGen, Application for Medical Inquiry and Nexus in Genornics (national clinical genetics referral platform); AMP, Association for Molecular Pathology; ATM, ataxia telangiectasia mutated gene; CERIST, ResearchCentre for Scientific and Technical Information; DzNA, Database of Algerian variants and allele frequencies; HPO, Human Phenotype Ontology; MH, malignant hyperthermia; ROH, runs of homozygosity; RYRl, ryanodine receptor 1 gene; VUS, variant of uncertain significance; WES, <t>whole-exome</t> sequencing.
Dna Double Stranded Capture Probe M010, supplied by MyGenostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capture+probes/pmc10228078-140-3-6?v=MyGenostics+Inc
Average 90 stars, based on 1 article reviews
dna double-stranded capture probe m010 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
gencap® mitochondrial loop gene capture probe v1.0  (MyGenostics Inc)
90
MyGenostics Inc gencap® mitochondrial loop gene capture probe v1.0
Key challenges encountered during autonomous WES implementation in Algeria, with contextual evidence and implemented or planned solutions. Challenges operate at two interconnected levels: interpretive (dark grey, relating to population underrepresentation, VUS burden, and consanguinity) and ethical/structural (medium grey, relating to incidental findings, infrastructure, and territorial access). Each challenge is paired with its evidentiary context and the corresponding response developed within this programme. ACMG, American College of Medical Genetics and Genomics; AI, artificial intelligence (here: in-house computational tools for variant prioritisation and interpretation); AMinGen, Application for Medical Inquiry and Nexus in Genornics (national clinical genetics referral platform); AMP, Association for Molecular Pathology; ATM, ataxia telangiectasia mutated gene; CERIST, ResearchCentre for Scientific and Technical Information; DzNA, Database of Algerian variants and allele frequencies; HPO, Human Phenotype Ontology; MH, malignant hyperthermia; ROH, runs of homozygosity; RYRl, ryanodine receptor 1 gene; VUS, variant of uncertain significance; WES, <t>whole-exome</t> sequencing.
Gencap® Mitochondrial Loop Gene Capture Probe V1.0, supplied by MyGenostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capture+probes/pmc09691460-74-32-39?v=MyGenostics+Inc
Average 90 stars, based on 1 article reviews
gencap® mitochondrial loop gene capture probe v1.0 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
5 -amine-functionalized oligonucleotide capture probes  (Biolegio bv)
90
Biolegio bv 5 -amine-functionalized oligonucleotide capture probes
Key challenges encountered during autonomous WES implementation in Algeria, with contextual evidence and implemented or planned solutions. Challenges operate at two interconnected levels: interpretive (dark grey, relating to population underrepresentation, VUS burden, and consanguinity) and ethical/structural (medium grey, relating to incidental findings, infrastructure, and territorial access). Each challenge is paired with its evidentiary context and the corresponding response developed within this programme. ACMG, American College of Medical Genetics and Genomics; AI, artificial intelligence (here: in-house computational tools for variant prioritisation and interpretation); AMinGen, Application for Medical Inquiry and Nexus in Genornics (national clinical genetics referral platform); AMP, Association for Molecular Pathology; ATM, ataxia telangiectasia mutated gene; CERIST, ResearchCentre for Scientific and Technical Information; DzNA, Database of Algerian variants and allele frequencies; HPO, Human Phenotype Ontology; MH, malignant hyperthermia; ROH, runs of homozygosity; RYRl, ryanodine receptor 1 gene; VUS, variant of uncertain significance; WES, <t>whole-exome</t> sequencing.
5 Amine Functionalized Oligonucleotide Capture Probes, supplied by Biolegio bv, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capture+probes/10__1128_slash_jcm__01606___10-85-2-10?v=Biolegio+bv
Average 90 stars, based on 1 article reviews
5 -amine-functionalized oligonucleotide capture probes - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
capture probes  (Midland Certified Reagent)
90
Midland Certified Reagent capture probes
Key challenges encountered during autonomous WES implementation in Algeria, with contextual evidence and implemented or planned solutions. Challenges operate at two interconnected levels: interpretive (dark grey, relating to population underrepresentation, VUS burden, and consanguinity) and ethical/structural (medium grey, relating to incidental findings, infrastructure, and territorial access). Each challenge is paired with its evidentiary context and the corresponding response developed within this programme. ACMG, American College of Medical Genetics and Genomics; AI, artificial intelligence (here: in-house computational tools for variant prioritisation and interpretation); AMinGen, Application for Medical Inquiry and Nexus in Genornics (national clinical genetics referral platform); AMP, Association for Molecular Pathology; ATM, ataxia telangiectasia mutated gene; CERIST, ResearchCentre for Scientific and Technical Information; DzNA, Database of Algerian variants and allele frequencies; HPO, Human Phenotype Ontology; MH, malignant hyperthermia; ROH, runs of homozygosity; RYRl, ryanodine receptor 1 gene; VUS, variant of uncertain significance; WES, <t>whole-exome</t> sequencing.
Capture Probes, supplied by Midland Certified Reagent, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capture+probes/pm12816901-57-2-10?v=Midland+Certified+Reagent
Average 90 stars, based on 1 article reviews
capture probes - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
syno® hybrid capture probe synthesis  (Synbio Technologies LLC)
90
Synbio Technologies LLC syno® hybrid capture probe synthesis
Key challenges encountered during autonomous WES implementation in Algeria, with contextual evidence and implemented or planned solutions. Challenges operate at two interconnected levels: interpretive (dark grey, relating to population underrepresentation, VUS burden, and consanguinity) and ethical/structural (medium grey, relating to incidental findings, infrastructure, and territorial access). Each challenge is paired with its evidentiary context and the corresponding response developed within this programme. ACMG, American College of Medical Genetics and Genomics; AI, artificial intelligence (here: in-house computational tools for variant prioritisation and interpretation); AMinGen, Application for Medical Inquiry and Nexus in Genornics (national clinical genetics referral platform); AMP, Association for Molecular Pathology; ATM, ataxia telangiectasia mutated gene; CERIST, ResearchCentre for Scientific and Technical Information; DzNA, Database of Algerian variants and allele frequencies; HPO, Human Phenotype Ontology; MH, malignant hyperthermia; ROH, runs of homozygosity; RYRl, ryanodine receptor 1 gene; VUS, variant of uncertain significance; WES, <t>whole-exome</t> sequencing.
Syno® Hybrid Capture Probe Synthesis, supplied by Synbio Technologies LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capture+probes/us12297508-196-2-0?v=Synbio+Technologies+LLC
Average 90 stars, based on 1 article reviews
syno® hybrid capture probe synthesis - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Key challenges encountered during autonomous WES implementation in Algeria, with contextual evidence and implemented or planned solutions. Challenges operate at two interconnected levels: interpretive (dark grey, relating to population underrepresentation, VUS burden, and consanguinity) and ethical/structural (medium grey, relating to incidental findings, infrastructure, and territorial access). Each challenge is paired with its evidentiary context and the corresponding response developed within this programme. ACMG, American College of Medical Genetics and Genomics; AI, artificial intelligence (here: in-house computational tools for variant prioritisation and interpretation); AMinGen, Application for Medical Inquiry and Nexus in Genornics (national clinical genetics referral platform); AMP, Association for Molecular Pathology; ATM, ataxia telangiectasia mutated gene; CERIST, ResearchCentre for Scientific and Technical Information; DzNA, Database of Algerian variants and allele frequencies; HPO, Human Phenotype Ontology; MH, malignant hyperthermia; ROH, runs of homozygosity; RYRl, ryanodine receptor 1 gene; VUS, variant of uncertain significance; WES, whole-exome sequencing.

Journal: medRxiv

Article Title: Challenges and perspectives in implementing whole-exome sequencing in Algeria: lessons from a fully autonomous in-country cohort

doi: 10.64898/2026.03.23.26348909

Figure Lengend Snippet: Key challenges encountered during autonomous WES implementation in Algeria, with contextual evidence and implemented or planned solutions. Challenges operate at two interconnected levels: interpretive (dark grey, relating to population underrepresentation, VUS burden, and consanguinity) and ethical/structural (medium grey, relating to incidental findings, infrastructure, and territorial access). Each challenge is paired with its evidentiary context and the corresponding response developed within this programme. ACMG, American College of Medical Genetics and Genomics; AI, artificial intelligence (here: in-house computational tools for variant prioritisation and interpretation); AMinGen, Application for Medical Inquiry and Nexus in Genornics (national clinical genetics referral platform); AMP, Association for Molecular Pathology; ATM, ataxia telangiectasia mutated gene; CERIST, ResearchCentre for Scientific and Technical Information; DzNA, Database of Algerian variants and allele frequencies; HPO, Human Phenotype Ontology; MH, malignant hyperthermia; ROH, runs of homozygosity; RYRl, ryanodine receptor 1 gene; VUS, variant of uncertain significance; WES, whole-exome sequencing.

Article Snippet: Exome enrichment targeting all coding exons and flanking canonical splice junctions within approximately ±50 bp was performed using the MGIEasy Exome Capture V5 probe set (MGI Tech).

Techniques: Variant Assay, Sequencing